Comments
Loading...

Salarius Pharmaceuticals

SLRXNASDAQ
Logo brought to you by Benzinga Data
$1.80
0.031.69%
Pre-Market: 8:25 AM EDT
15 minutes delayed

Salarius Pharmaceuticals (NASDAQ:SLRX) Stock, Earnings Estimates, EPS, And Revenue

Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS Estimate
$-2.400
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)

Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Salarius Pharmaceuticals (SLRX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-09$-2.37$-53.6095.6 %
Mar 20242024-05-13$-3.28$-53.6093.9 %
Dec 20232024-03-22$-1.76$-8.0878.2 %
Sep 20232023-11-09$-5.20$-9.6045.8 %

Salarius Pharmaceuticals (SLRX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Dec 20212022-03-10$0$430.00K-100.0 %
Sep 20212021-11-04$0$1.16M-100.0 %
Jun 20212021-08-05$571.39K$1.28M-55.4 %
Mar 20212021-05-12$1.27M$1.37M-7.37 %

FAQ

Q

When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?

A

Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Salarius Pharmaceuticals (NASDAQ:SLRX)?

A

The Actual EPS was $-2.37, which beat the estimate of $-53.60.

Q

What were Salarius Pharmaceuticals’s (NASDAQ:SLRX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch